Rickettsial and ehrlichial infections

Handbook of Clinical Neurology

Volumn 96, Issue C, 2010, Pages 143-158

  Glaser, Carol ^a   Christie, Laura ^b   Bloch, Karen C ^c  

^a Viral and Rickettsial Disease Laboratory   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954331742     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(09)96010-9     Document Type: Article

References (121)

1. Allen AC, Saitz S (1945). A comparative study of the pathology of scrub typhus (Tsutsugamushi disease) and other rickettsial diseases. Am J Pathol 21: 603-681.
2. Azad AF (1990). Epidemiology of murine typhus. Annu Rev Entomol 35: 553-569.
3. Baganz MD, Dross PE, Reinhardt JA (1995). Rocky Mountain spotted fever encephalitis: MR findings. Am J Neuroradiol 16: 919-922.
4. Bakken JS, Dumler JS, Chen SM, et al. (1994). Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? [see comment]. JAMA 272: 212-218.
5. Bakken JS, Krueth J, Wilson-Nordskog C, et al. (1996). Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275: 199-205.
6. Bakken JS, Goellner P, Van Etten M, et al. (1998). Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis 27: 1491-1496.
7. Bakken JS, Aguero-Rosenfeld ME, Tilden RL, et al. (2001). Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis 32: 862-870.
8. Bernit E, Pouget J, Janbon F, et al. (2002). Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med 162: 693-700.
9. Berry DS, Miller ES, Hooke JA, et al. (1999). Ehrlichial meningitis with cerebrospinal fluid morulae. Pediatr Infect Dis J 18: 552-555.
10. Bitsori M, Galanakis E, Gikas A, et al. (2002). Rickettsia typhi infection in childhood. Acta Paediatr 91: 59-61.
11. Bloch KC, Tang YW, Hillstron L (2005). Predictors of tickborne ricketttsial disease among patients hospitalized with encephalitis. In: Infectious Diseases Society of America, San Francisco, CA.
12. Bozeman FM, Masiello SA, Williams MS, et al. (1975). Epidemic typhus rickettsiae isolated from flying squirrels. Nature 255: 545-547.
13. Brooks RG, Licitra CM, Peacock MG (1986). Encephalitis caused by Coxiella burnetii. Ann Neurol 20: 91-93.
14. Buckingham SC, Marshall GS, Schutze GE, et al. (2007). Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr 150: 180-184.
15. Buitrago MI, Ijdo JW, Rinaudo P, et al. (1998). Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin Infect Dis 27: 213-215.
16. Buller RS, Arens M, Hmiel SP, et al. (1999). Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med. 341: 148-155.
17. Cameron DA, Freedman AR, Wansbrough-Jones MH (1990). Q fever encephalitis. J Infect 20: 159-162.
18. Carter N, Miller NR (1997). Fourth nerve palsy caused by Ehrlichia chaffeensis. J Neuroophthalmol 17: 47-50.
19. CDC (1982). Epidemic typhus associated with flying squirrels United States. MMWR 31: 555-6561.
20. CDC (1991). Current trends Rocky Mountain Spotted FeverUnited States, 1990. MMWR 40:451-453.
21. CDC (1992). Summary of notifiable diseases, United States, 1991. MMWR 40: 34.
22. CDC (2000). Consequences of delayed diagnosis of RMSF in children - West Virginia, Michigan, Tennessee, and Oklahoma May-July 2000. MMWR 49: 885-888.
23. CDC (2004). Fatal cases of Rocky Mountain spotted fever in family clusters - three states, 2003. MMWR 53: 407-410.
24. CDC (2006). Diagnosis and management of tick-borne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis - United States: a practical guide for physicians and other health-care and public health professionals. MMWR 55: 1-27.
25. Childs JE, Sumner JW, Nicholson WL, et al. (1999). Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol 37: 2997-3000.
26. Clark WH, Lennette EH, Railsback OC, et al. (1951). Q fever in California. VII. Clinical features in one hundred eighty cases. Arch Intern Med 88: 155-167.
27. Dalton MJ, Clarke MJ, Holman RC, et al. (1995). National surveillance for Rocky Mountain spotted fever, 1981-1992:
28. epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 52:405-413.
29. Demma LJ, Holman RC, McQuiston JH, et al. (2005). Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am J Trop Med Hyg 73: 400-409.
30. Dhand A, Nadelman RB, Aguero-Rosenfeld M, et al. (2007). Human granulocytic anaplasmosis during pregnancy: case series and literature review. Clin Infect Dis 45: 589-593.
31. Diaz Ortuno A, Maeztu C, Munoz JA, et al. (1990). Miller Fisher syndrome associated with Q fever. J Neurol Neurosurg Psychiatry 53: 615-616.
32. Drancourt M, Raoult D, Xeridat B, et al. (1991). Q fever meningoencephalitis in five patients. Eur J Epidemiol 7: 134-138.
33. Dumler JS, Taylor JP, Walker DH (1991). Clinical and laboratory features of murine typhus in south Texas, 1980 through 1987. JAMA 266: 1365-1370.
34. Dumler JS, Madigan JE, Pusterla N, et al. (2007). Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 45: S45-S51.
35. Dunn BE, Monson TP, Dumler JS, et al. (1992). Identification of Ehrlichia chaffeensis morulae in cerebrospinal fluid mononuclear cells. J Clin Microbiol 30: 2207-2210.
36. Elghetany MT, Walker DH (1999). Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever. Am J Clin Pathol 112: 159-168.
37. Eng TR, Harkess JR, Fishbein DB, et al. (1990). Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 264: 2251-2258.
38. Everett ED, Evans KA, Henry RB, et al. (1994). Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 120: 730-735.
39. Ferrante MA, Dolan MJ (1993). Q fever meningoencephalitis in a soldier returning from the Persian Gulf War. Clin Infect Dis 16: 489-496.
40. Fichtenbaum CJ, Peterson LR, Weil GJ (1993). Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. Am J Med 95: 351-357.
41. Fishbein DB, Dawson JE, Robinson LE (1994). Human ehrlichiosis in the US 1985-90. Ann Intern Med 130: 736-743.
42. Galanakis E, Gikas A, Bitsori M, et al. (2002). Rickettsia typhi infection presenting as subacute meningitis. J Child Neurol 17: 156-157.
43. Gallaher WH (1961). Q fever. JAMA 177: 187-189.
44. Gelston AL, Jones TC (1977). Typhus fever: report of an epidemic in New York City in 1847. J Infect Dis 136: 813-821.
45. Gorman RJ, Saxon S, Snead OC (1981). Neurologic sequelae of Rocky Mountain spotted fever. Pediatrics 67: 354-357.
46. Grant AC, Hunter S, Partin WC (1997). A case of acute monocytic ehrlichiosis with prominent neurologic signs. Neurology 48: 1619-1623.
47. Hamburg BJ, Storch GA, Micek ST, et al. (2008). The importance of early treatment with doxycycline in human ehrlichiosis. Medicine 87: 53-60.
48. Hamilton KS, Standaert SM, Kinney MC (2004). Characteristic peripheral blood findings in human ehrlichiosis. Mod Pathol 17: 512-517.
49. Harkess JR, Stucky D, Ewing SA (1990). Neurologic abnormalities in a patient with human ehrlichiosis. South Med. J 83: 1341-1343.
50. Harrell GT (1953). Rickettsial involvement of the nervous system. In: The Medical Clinics of North America, W. B Saunders Company, Philadephia.
51. Hongo I, Bloch KC (2006). Ehrlichia infection of the central nervous system. Curr Treat Options Neurol 8: 179-184.
52. Horowitz HW, Marks SJ, Weintraub M, et al. (1996). Brachial plexopathy associated with human granulocytic ehrlichiosis. Neurology 46: 1026-1029.
53. Ismail N, Walker DH (2005). Balancing protective immunity and immunopathology: a unifying model of monocytotropic ehrlichiosis. Ann N Y Acad Sci 1063: 383-394.
54. Jones TF, Craig AS, Paddock CD, et al. (1999). Family cluster of Rocky Mountain spotted fever. Clin Infect Dis 28: 853-859.
55. Kaplowitz LG, Fischer JJ, Sparling PF (1981). Rocky Mountain spotted fever: a clinical dilemma. Curr Clin Top Infect Dis 2: 89-108.
56. Katavolos P, Armstrong PM, Dawson JE, et al. (1998). Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J Infect Dis 177: 1422-1425.
57. Kelsey DS (1979). Rocky Mountain spotted fever. Pediatr Clin North Am 26: 367-376.
58. Kim JH, Durack DT (1997). Rickettsia. In: WM Scheid, RJ Whitely, DT Durack (Eds.), Infections of the Central Nervous System. Lippincott-Raven, Philadelphia.
59. Kirk JL, Fine DP, Sexton DJ, et al. (1990). Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine 69: 35-45.
60. Lee FS, Chu FK, Tackley M, et al. (2000). Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman. Clin Infect Dis 31: 1288-1291.
61. Lillie RD (1941). The Pathology of Rocky Mountain Spotted Fever, vol. 177. National Institute of Health Bulletin. United States Government Printing Office, Washington, DC.
62. Lochary ME, Lockhart PB, Williams WT Jr (1998). Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 17: 429-431.
63. Marrie TJ, Raoult D (1992). Rickettsial infections of the central nervous system. Semin Neurol 12: 213-224.
64. Marshall GS, Jacobs RF, Schutze GE, et al. (2002). Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States. Arch Pediatr Adolesc Med 156: 166-170.
65. Masalha R, Merkin-Zaborsky H, Matar M, et al. (1998). Murine typhus presenting as subacute meningoencephalitis. J Neurol 245: 665-668.
66. Maurin M, Raoult D (1999). Q fever. Clin Microbiol Rev 12: 518-553.
67. Miller ES, Beeson PB (1946). Murine typhus fever. Medicine 25: 1-15.
68. Miller JQ, Price TR (1972). The nervous sytem in Rocky Mountain spotted fever. Neurology 22: 561.
69. Miller MB, Blankenship R, Bratton JL, et al. (1974). Murine typhus in Vietnam. Mil Med 139: 184-186.
70. Mixson TR, Campbell SR, Gill JS, et al. (2006). Prevalence of Ehrlichia, Borrelia, and rickettsial agents in Amblyomma americanum (Acari: Ixodidae) collected from nine states. J Med Entornol 43: 1261-1268.
71. Mokrani K, Fournier PE, Dalichaouche M, et al. (2004). Reemerging threat of epidemic typhus in Algeria. J Clin Microbiol 42: 3898-3900.
72. Nadelman RB, Horowitz HW, Hsieh TC, et al. (1997). Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis [see comment]. N Engl. J Med. 337: 27-30.
73. Olano JP, Masters E, Hogrefe W, et al. (2003). Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis 9: 1579-1586.
74. Paddock CD, Greer PW, Ferebee TL, et al. (1999). Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 179: 1469-1476.
75. Paddock CD, Folk SM, Shore GM, et al. (2001). Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 33: 1586-1594.
76. Paddock CD, Brenner O, Vaid C, et al. (2002). Short report: concurrent Rocky Mountain spotted fever in a dog and its owner. Am J Trop Med Hyg 66: 197-199.
77. Paddock CD, Sumner JW, Comer JA, et al. (2004). Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis 38: 805-811.
78. Parola P, Paddock CD, Raoult D (2005). Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 18: 719-756.
79. Patterson KD (1993). Typhus and its control in Russia, 1870-1940. Med Hist 37: 361-381.
80. Perine PL, Chandler BP, Krause DK, et al. (1992). A clinicoepidemiological study of epidemic typhus in Africa. Clin Infect Dis 14: 1149-1158.
81. Peters TR, Edwards KM, Standaert SM (2000). Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole. Pediatr Infect Dis J 19: 170-172.
82. Pratt HD (1958). The changing picture of murine typhus in the US. Ann N Y Acad Sci 70: 516-527.
83. Raab EL, Leopold IH, Hodes HL (1969). Retinopathy in Rocky Mountain spotted fever. Am J Ophthalmol 68:42-46.
84. Raoult D (1993). Treatment of Q fever. Antimicrob Agents Chemother 37: 1733-1736.
85. Raoult D (2004). A new rickettsial disease in the United States. Clin Infect Dis 38: 812-813.
86. Raoult D, Roux V (1999). The body louse as a vector of reemerging human diseases. Clin Infect Dis 29: 888-911.
87. Raoult D, Rous V, Ndihokubwayo JB, et al. (1997). Jail fever (epidemic typhus) outbreak in Burundi. Emerg Infect Dis 3: 357-360.
88. Raoult D, Ndihokubwayo JB, Tissot-Dupont H, et al. (1998). Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet 352: 353-358.
89. Raoult D, Woodward T, Dumler JS (2004). The history of epidemic typhus. Infect Dis Clin North Am 18: 127-140.
90. Ratnasamy N, Everett ED, Roland WE, et al. (1996). Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis 23: 314-319.
91. Reilly S, Northwood JL, Caul EO (1990). Q fever in Plymouth, 1972-88. A review with particular reference to neurological manifestations. Epidemiol Infect 105: 391-408.
92. Rikihisa Y (2006). Ehrlichia subversion of host innate responses. Curr Opin Microbiol 9: 95-101.
93. Rosenblum MJ, Masland RL, Harrell GT (1952). Residual effects of rickettsial disease on the central nervous system; results of neurologic examinations and electroencephalograms following Rocky Mountain spotted fever. Arch Intern Med 90: 444-455.
94. Schuil J, Richardus JH, Baarsma GS, et al. (1985). Q fever as a possible cause of bilateral optic neuritis. Br J Ophthalmol 69: 580-583.
95. Schutze GE (2006). Ehrlichiosis. Pediatr Infect Dis J 25: 71-72.
96. Schutze GE, Jacobs RF (1997). Human monocytic ehrlichiosis in children. Pediatrics 100: E10.
97. Schutze GE, Buckingham SC, Marshall GS, et al. (2007). Human monocytic ehrlichiosis in children. Pediatr Infect Dis J 26: 475-479.
98. Schwartz RB (1974). Manic psychosis in connection with Q-fever. Br J Psychiatry 124: 140-143.
99. Sexton DJ, Corey GR (1992). Rocky Mountain "spotless" and "almost spotless" fever: a wolf in sheep's clothing. Clin Infect Dis 15: 439-448.
100. Sexton DJ, Kaye KS (2002). Rocky Mountain spotted fever. Med Clin North Am 86: 351-360.
101. Sexton DJ, Corey GR, Carpenter C, et al. (1998). Dual infection with Ehrlichia chaffeensis and a spotted fever group rickettsial a case report [see comment]. Emerg Infect Dis 4: 311-316.
102. Shaked Y, Samra Y (1989). Q fever meningoencephalitis associated with bilateral abducens nerve paralysis, bilateral optic neuritis and abnormal cerebrospinal fluid findings. Infection 17: 394-395.
103. Silpapojakul K, Ukkachoke C, Krisanapan S, et al. (1991). Rickettsial meningitis and encephalitis. Arch Intern Med. 151: 1753-1757.
104. Smith TW, Burton TC (1977). The retinal manifestations of Rocky Mountain spotted fever. Am J Ophthalmol 84: 259-262.
105. Spelman DW (1982). Q fever: a study of 111 consecutive cases. Med. J Aust 1: 547-548.
106. Standaert SM, Clough LA, Schffner W (1998). Neurologic manifestations of human monocytic ehrlichiosis. Infect Dis Clin Pract 7: 358-362.
107. Standaert SM, Yu T, Scott MA, et al. (2000). Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J Infect Dis 181: 1082-1088.
108. Tarasevich I, Rydkina E, Raoult D (1998). Outbreak of epidemic typhus in Russia. Lancet 352: 1151.
109. Thomas LD, Hongo I, Bloch KC, et al. (2007). Human ehrlichiosis in transplant recipients. Am J Transplant 7: 1641-1647.
110. Thorner AR, Walker DH, Petri WA, Jr (1998). Rocky Mountain spotted fever. Clin Infect Dis 27: 1353-1359.
111. Toerner JG, Kumar PN, Garagusi VF (1996). Guillain-Barré syndrome associated with Rocky Mountain spotted fever: case report and review. Clin Infect Dis 22: 1090-1091.
112. Walker DH (1995). Rocky Mountain spotted fever: a seasonal alert. Clin Infect Dis 20: 1111-1117.
113. Walker DH, Mattem WD (1980). Rickettsial vasculitis. Am Heart J 100: 896-906.
114. Walker DH, Parks FM, Betz TG, et al. (1989). Histopathology and immunohistologic demonstration of the distribution of Rickettsia typhi in fatal murine typhus. Am J Clin Pathol 91: 720-724.
115. Whiteford SF, Taylor JP, Dumler JS (2001). Clinical, laboratory, and epidemiologic features of murine typhus in 97 Texas children. Arch Pediatr Adolesc Med 155: 396-400.
116. WHO (1997). A large outbreak of epidemic louse-borne typhus in Burundi. Wkly Epidemiol Rec 72: 152-153.
117. Wormser GP, Dattwyler RJ, Shapiro ED, et al. (2006). The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43: 1089-1134.
118. Wright L (1972). Intellectual sequelae of Rocky Mountain spotted fever. J Abnorm Psychol 80: 315-316.
119. Yevich SJ, Sanchez JL, DeFraites RF, et al. (1995). Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis 171: 1266-1273.
120. Young NP, Klein CJ (2007). Encephalopathy with seizures having PCR-positive Anaplasma phagocytophilum and Ehrlichia chaffeensis. Eur J Neurol 14: e3-e4.
121. Zinsser H (1935). Rats, Lice and History. Little, Brown, Boston, MA.